• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma USA 2023: Digital Therapeutics and Pharma

Article

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Tracey Dodenhoff, CEO of Medly Therapeutics, discusses her company's heart failure app and why pharma should consider prescription digital therapeutics among their offerings.

Recent Videos
Related Content
ROI and Rare Disease: Retooling the ‘Gene’ Value Machine

ROI and Rare Disease: Retooling the ‘Gene’ Value Machine

Marc Blaustein, CFA;Kenneth Getz, MBA
November 14th 2024
Article

Framework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.

The Leap Forward: Practical Gains for Pharma AI Use

The Leap Forward: Practical Gains for Pharma AI Use

Bianca Anghelina;Helen Merianos;Ruth Beadle
November 14th 2024
Article

Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.

Powering Pipelines Forward: Approach Science Differently

Powering Pipelines Forward: Approach Science Differently

Irfan Qureshi, MD
November 13th 2024
Article

Why tapping the value generated for the next set of therapies is critical.

Vaccines After COVID: Biopharma's Renewed Public Health and Commercial Push

Vaccines After COVID: Biopharma's Renewed Public Health and Commercial Push

Don Tracy, Associate Editor
November 8th 2024
Article

At the Financial Times’ Global Pharma and Biotech Summit 2024, a panel discussed the potential of mRNA technology in developing cancer vaccines amid distrust from the public.

Stock.adobe.com

Financial Times Global Pharma and Biotech Summit: The Impact of the Election

Mike Hollan
November 7th 2024
Article

How will President Trump’s return to office impact the pharma industry?

Strategies for the Looming Pharma Patent Cliff

Strategies for the Looming Pharma Patent Cliff

Don Tracy, Associate Editor
November 7th 2024
Article

At the Financial Times’ Global Pharma and Biotech Summit 2024, a panel discussed ways to prepare for the high number of incoming patent expiries and how to protect key drugs.